Clinical Trial Update: Intracoronary Transplantation of Bone Marrow Derived Mononuclear Cells in Pediatric Cardiomyopathy [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating intracoronary transplantation of bone marrow-derived mononuclear cells in pediatric cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy

Drugs mentioned

• bone marrow-derived mononuclear cells

Snippet

Sponsor: Nasser Aghdami MD., PhD | Conditions: Cardiomyopathy | Phase 1, Phase 2 | Status: COMPLETED